Sun Pharma launches Infugem in US market
Sun Pharma launches Infugem in US market

Sun Pharma launches Infugem in US market

Shohini Nath Article rating: 5.0

Sun Pharma has declared the launch of Infugem which will be available commercially in the US. Infugem is the very first and only chemotherapy product available in a premixed and ready-to-infuse formulation. The shares of Sun Pharma opened in green on Monday.


Lakshmi Vilas opens in upper circuit on valuation premium
Lakshmi Vilas opens in upper circuit on valuation premium

Lakshmi Vilas opens in upper circuit on valuation premium

Gayathri Udyawar Article rating: 5.0

The proposed swap ratio for the Lakshmi Vilas Bank and IndiaBulls Housing (IBH) merger is at a premium to the bank's current share price. The stock hit its upper circuit limit of 5 per cent at Rs. 97.35 per share in Monday's opening session.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 92.33 lakhs contracts with a turnover of Rs. 6,23,820.25 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 92.33 lakhs contracts with a turnover of Rs. 6,23,820.25 crore.

Baring PE to acquire 30 per cent in NIIT Tech
Baring PE to acquire 30 per cent in NIIT Tech

Baring PE to acquire 30 per cent in NIIT Tech

Advait Dharmadhikari Article rating: 5.0

NIIT Tech announced that funds affiliated with Baring Private Equity Asia (BPEA) have signed definitive agreements to purchase 30 per cent shareholding of NIIT Tech from NIIT and other promoter entities, leading to an open offer at a price of Rs. 1,394 per share.

Ambuja Cement forms Homing Pigeon pattern
Ambuja Cement forms Homing Pigeon pattern

Ambuja Cement forms Homing Pigeon pattern

Vinayak Gangule Article rating: 5.0

Ambuja Cement forms Homing Pigeon candlestick pattern on daily time frame. Homing pigeon closely resembles the harami or inside day pattern, except the both bodies are red rather than opposite in colour.

Index trend and stocks in action April 08, 2019
Index trend and stocks in action April 08, 2019

Index trend and stocks in action April 08, 2019

Karan Dsij Article rating: 5.0

The 8-day moving average, which is placed around 11616, is likely to act as an immediate support, while the major support is placed around 11,559, which is the low of last week. On the upside, 11,760 is likely to act as a resistance level and sustaining above this level decisively would lead to further acceleration of upward momentum. Stock in news: NIIT Technologies, Eris Lifesciences, Lumax Auto Technologies, Torrent Pharma, Colgate Palmolive (India), Tata Steel, Cadila Healthcare, Infosys.

Markets may open flat with a positive bias amid positive global cues
Markets may open flat with a positive bias amid positive global cues

Markets may open flat with a positive bias amid positive global cues

Karan Dsij Article rating: 5.0

Indian equity benchmark indices are likely to open the new week on a flat note with a positive bias. The market participants will monitor the earning season which starts this week and that will be a key trigger for the markets. Also, the big event of the general election starts this week with the first round of polling on April 11. At the time of writing, SGX Nifty was trading around 11,776 level, up by 3 points.

Overnight Digest: Stocks to watch out on April 8
Overnight Digest: Stocks to watch out on April 8

Overnight Digest: Stocks to watch out on April 8

Advait Dharmadhikari Article rating: 4.5

The stocks that are likely to witness significant movement on the bourses on April 8 are, CMI Ltd, Syngene, Precision Camshafts, Indiabulls Housing Finance, Lakshmi Vilas Bank and Ahluwalia Contracts

RSS
First27262727272827292731273327342735Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR